Lactic acid bacteria--20 years exploring their potential as live vectors for mucosal vaccination.
about
Heterologous Expression and Delivery of Biologically Active Exendin-4 by Lactobacillus paracasei L14Lactobacillus plantarum producing a Chlamydia trachomatis antigen induces a specific IgA response after mucosal booster immunization.Development of a counterselectable seamless mutagenesis system in lactic acid bacteria.Recombinant Lactococcus lactis NZ9000 secretes a bioactive kisspeptin that inhibits proliferation and migration of human colon carcinoma HT-29 cells.An engineered food-grade Lactococcus lactis strain for production and delivery of heat-labile enterotoxin B subunit to mucosal sitesCell Wall Anchoring of the Campylobacter Antigens to Lactococcus lactis.Development of a simple, low-cost and eurytopic medium based on Pleurotus eryngii for lactic acid bacteriaImmunogenic Properties of Lactobacillus plantarum Producing Surface-Displayed Mycobacterium tuberculosis Antigens.Intracellular and Extracellular Expression of Bacillus thuringiensis Crystal Protein Cry5B in Lactococcus lactis for Use as an Anthelminthic.Advances and needs for endotoxin-free production strains.Recombinant Lactococcus lactis expressing bioactive exendin-4 to promote insulin secretion and beta-cell proliferation in vitro.Immunomodulatory effects of Lactobacillus strains: emphasis on their effects on cancer cells.Gas-filled microbubbles: Novel mucosal antigen-delivery system for induction of anti-pathogen's immune responses in the gut.Lactobacillus plantarum displaying CCL3 chemokine in fusion with HIV-1 Gag derived antigen causes increased recruitment of T cells.Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules.Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases.Phytases of Probiotic Bacteria: Characteristics and Beneficial Aspects.In vitro characteristics of Lactobacillus spp. strains isolated from the chicken digestive tract and their role in the inhibition of Campylobacter colonization.Heterologous expression of Streptococcus mutans Cnm in Lactococcus lactis promotes intracellular invasion, adhesion to human cardiac tissues and virulence.Construction of a recombinant Lactococcus lactis strain expressing a fusion protein of Omp22 and HpaA from Helicobacter pylori for oral vaccine development.Oral immunization of mice with engineered Lactobacillus gasseri NM713 strain expressing Streptococcus pyogenes M6 antigen.Development and evaluation of an efficient heterologous gene knock-in reporter system in Lactococcus lactis.Recombinant Mouse Osteocalcin Secreted by Lactococcus lactis Promotes Glucagon-Like Peptide-1 Induction in STC-1 Cells.Lactococcus lactis : A New Strategy for Vaccination.The Evolution of gene regulation research in Lactococcus lactis.PilVax - a novel peptide delivery platform for the development of mucosal vaccines.Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.Live Bacterial Vectors-A Promising DNA Vaccine Delivery System.Lactobacillus Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens.Microbial Delivery Vehicles for Allergens and Allergen-Derived Peptides in Immunotherapy of Allergic Diseases.Engineering Components of the S-Layer for Biotherapeutic ApplicationsLactic Acid Bacteria for Delivery of Endogenous or Engineered Therapeutic Molecules
P2860
Q28552845-737F1482-F7AC-4FF4-AC86-07F74824A1D5Q33632705-ED9B66DD-179A-4E55-AAFD-D7FFD58BD156Q33876938-B633AD34-0BA2-473F-A0FB-67C688EAAD3EQ34530446-76EE35CC-ED8F-4EAC-8092-A2FCD0926814Q36298813-868BD46D-A3D6-497A-B865-CBE3217B448DQ36591005-E012B7D0-822A-4F7E-B738-E45A7B1BD18FQ37230486-C896B47C-978C-4C5E-8BA4-F33809781A1BQ37546883-8589BE79-DA89-4F4C-94CB-6B8F3436A2F1Q38386911-F35BF925-1C18-4EAE-9A0C-68204367CAF7Q38585347-80767BC0-5AF5-41E8-9110-58E6088A4B2CQ38614829-43D52187-28F5-4786-AE10-264C48678D4EQ38643527-5138A667-F963-43FC-8E95-12CDB5DD1946Q38765335-437930D0-029F-4E91-9809-E099F21EABCDQ38825666-556367EE-0F75-45B2-B683-69E02A5AA78EQ39025466-ED11F406-219D-494A-BCB0-5B866EDE1C69Q39127400-6167FF91-65B7-4472-BACD-496162AA9D8EQ39370727-F626490A-158D-49BA-A22D-9E70A51346FEQ40111124-C7D81F92-05EA-4BC3-9968-BB432D83E096Q40646110-A21624A8-FCEC-4AC7-A858-D3CED0226573Q40654441-7C69656B-5929-4AC0-A809-53421766E2BBQ40701445-1E387330-2111-42EB-9919-B81E77D7EB4CQ41707965-B89A6945-9BA5-471F-99CA-39C8A939CD1AQ46307319-98D2D6C7-0187-44B5-A05B-87EB8A843DD7Q47150132-351EF985-E338-4E26-AA0A-26C4CF8D2CF8Q47920889-5AF426DA-21CD-4AF7-B004-18C956186505Q48507555-05A202B7-EF53-4B27-98B4-AEBBEB3D9B1EQ50532218-0BC0F260-6CDC-423D-970E-A5DB947C35FAQ52640510-A653E9E8-F85E-495C-9281-76DE11394D78Q55195653-A70BEB52-E199-48DE-8005-9C375E603E25Q55693712-A3765DD1-A458-4D2E-9EB8-D3196CF327E5Q58586624-8CA4E43A-042A-4F22-9C74-D9ADBF883CF9Q58801803-F7EA282A-8F0A-42B3-88F8-85419C759326
P2860
Lactic acid bacteria--20 years exploring their potential as live vectors for mucosal vaccination.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Lactic acid bacteria--20 years ...... ctors for mucosal vaccination.
@ast
Lactic acid bacteria--20 years ...... ctors for mucosal vaccination.
@en
type
label
Lactic acid bacteria--20 years ...... ctors for mucosal vaccination.
@ast
Lactic acid bacteria--20 years ...... ctors for mucosal vaccination.
@en
prefLabel
Lactic acid bacteria--20 years ...... ctors for mucosal vaccination.
@ast
Lactic acid bacteria--20 years ...... ctors for mucosal vaccination.
@en
P2860
P921
P1476
Lactic acid bacteria--20 years ...... ctors for mucosal vaccination.
@en
P2093
Jacek Bardowski
Patrycja Kobierecka
P2860
P2888
P304
P356
10.1007/S00253-015-6498-0
P407
P577
2015-03-10T00:00:00Z
2015-04-01T00:00:00Z